NDC 51429-010 - Neo-Oxy 100/100 MR
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51429-010
- Package NDCs from labels
- 51429-010-03
- Manufacturer
- Pharmgate Animal Health | Pharmgate Inc.
- Effective date
- 2026-01-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Neo-Oxy 100/100 MR ® | Pharmgate Animal Health | Pharmgate Inc. | 2026-01-07 | VFD TYPE A MEDICATED ARTICLE ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51429-010-03 | Neo-Oxy 100/100 MR | 22.68 kg in 1 DRUM | POWDER | 22.68 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Neomycin Sulfate | ACTIVE INGREDIENT | 057Y626693 | NEO-OXY 100/100 MR (OXYTETRACYCLINE HYDROCHLORIDE AND NEOMYCIN SULFATE) POWDER [PHARMGATE ANIMAL HEALTH] | 1 | |
| Oxytetracycline Hydrochloride | ACTIVE INGREDIENT | 4U7K4N52ZM | NEO-OXY 100/100 MR (OXYTETRACYCLINE HYDROCHLORIDE AND NEOMYCIN SULFATE) POWDER [PHARMGATE ANIMAL HEALTH] | 1 | |
| Neomycin | ACTIVE MOIETY | I16QD7X297 | NEO-OXY 100/100 MR (OXYTETRACYCLINE HYDROCHLORIDE AND NEOMYCIN SULFATE) POWDER [PHARMGATE ANIMAL HEALTH] | 1 | |
| Oxytetracycline Anhydrous | ACTIVE MOIETY | SLF0D9077S | NEO-OXY 100/100 MR (OXYTETRACYCLINE HYDROCHLORIDE AND NEOMYCIN SULFATE) POWDER [PHARMGATE ANIMAL HEALTH] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Major Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B SULFAT | Major Pharmaceuticals | a6cc3fbc-6302-4033-e053-2a95a90a19f0 | 2024-09-11 | Warnings | 057Y626693 |
| Leader Triple antibiotic | BACITRACIN,NEOMYCIN,POLYMXIN | Cardinal Health 110 dba LEADER | 2175e00a-bf85-3377-e063-6394a90a916f | 2024-09-06 | Warnings | 057Y626693 |
| Members Mark Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B | Sam's West Inc | 200f4020-7699-4a9e-8fab-2d3df9e76836 | 2024-09-05 | Warnings | 057Y626693 |
| triple antibiotic | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B | Meijer Distribution Inc | edcb423e-b5c2-4e26-8f7f-9b9ee575042c | 2024-08-19 | Warnings | 057Y626693 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Wildeman Business Group | 1f96450a-3bda-1f0a-e063-6294a90a514f | 2024-08-13 | Warnings | 057Y626693 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Provision Medical | bbf4b99c-9738-4855-82a6-f4e213924ec9 | 2024-08-09 | Warnings | 057Y626693 |
| Cortisporin TC | COLISTIN SULFATE, NEOMYCIN SULFATE, THONZONIUM BROMIDE AND HYDROCORTISONE ACETATE | Endo USA, Inc. | 9c6fc1c7-3350-42ae-b999-aca48e704bb1 | 2024-08-01 | Warnings, Adverse reactions | 057Y626693 |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | NuCare Pharmaceuticals,Inc. | 54da7bef-c3b0-4353-e054-00144ff8d46c | 2024-07-10 | Warnings, Adverse reactions | 057Y626693 |
| Publix Triple Antibiotic | BACITRACIN ZINC 400 U, POLYMXYIN B SULFATE 5,000 U, NEOMYCIN SULFATE 3.5MG/G | PUBLIX SUPER MARKETS, INC. | 871fa43c-a1be-4c15-bbfa-a998a2d89d2e | 2024-06-17 | Warnings | 057Y626693 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension | NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE OTIC | Rising Pharma Holdings, Inc. | 35768adc-b578-4c2e-b461-22de3135a789 | 2024-06-10 | Warnings, Adverse reactions | 057Y626693 |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE | A-S Medication Solutions | 6791e6c3-514d-4b98-8887-ca2b894576b5 | 2024-06-10 | Warnings, Adverse reactions | 057Y626693 |
| Neomycin Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | NuCare Pharmaceuticals,Inc. | 691bc5ca-5d61-60c2-e053-2991aa0abb93 | 2024-06-07 | Warnings, Adverse reactions | 057Y626693 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, HYDROCORTISONE | NuCare Pharmaceuticals,Inc. | 5f9c25b1-67d0-11ae-e053-2a91aa0ad8f4 | 2024-06-06 | Boxed warning, Warnings, Adverse reactions | 057Y626693 |
| QC Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE , POLYMYXIN B SULFATE. | Chain Drug Marketing Association | 1a1501a4-75b0-5900-e063-6394a90ad77a | 2024-06-04 | Warnings | 057Y626693 |
| PENTREXCILINA TRIPLE ANTIBIOTIC PLUS PAIN RELIEF | BACITRACIN, NEOMYCIN, POLYMYXIN B, PRAMOXINE | OPMX LLC | 7c0d3cdf-af50-4a65-a01b-a33510feeb94 | 2024-05-17 | Warnings | 057Y626693 |
| PENIMIXCINA | BACITRACIN, NEOMYCIN SULFATE, POLYMIXIN B SULFATE, PRAMOXINE HYDROCHLORIDE | OPMX LLC | 92bcbc02-9683-4117-af2b-6d4687796f1f | 2024-05-17 | Warnings | 057Y626693 |
| Triple Antibiotic First Aid Antibiotic | BACITRACIN ZINC, NEOMYCIN AND POLYMYXIN B SULFATE | Universal Distribution Center LLC | 78f00296-267b-44c3-a9e3-c40f122e905e | 2024-05-14 | Warnings | 057Y626693 |
| TRIPLE ANTIBIOTIC | BACITRACIN ZINC, NEOMYCIN SULFATE, AND POLYMYXIN B SULFATE | JHK Inc dba American Safety & First Aid | 26e66025-9457-42b3-9319-51302c17506e | 2024-04-26 | Warnings | 057Y626693 |
| First Aid Antibiotic Bacitracin Zinc Neomycin Sulfate Polymyxin B Sulfate | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | M-star (Hubei) Health&Care Products Co., Ltd. | c6f2656e-b822-4d61-b557-dd2046dd51f5 | 2024-04-01 | Warnings | 057Y626693 |
| UniShield TRIPLE ANTIBIOTIC | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Unishield | 00b85d3a-322b-43c1-b022-5f6ed50c6609 | 2024-03-02 | Warnings | 057Y626693 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.